Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01792544 · ClinicalTrials.gov registry record · NA
Clinical Reminders in Test Reports to Improve Guideline Compliance
A NA study of Echocardiography, sponsored by VA Palo Alto Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 1,706
- Enrollment target
- 1
- Study location
NCT01792544: Completed NA study of Echocardiography, sponsored by VA Palo Alto Health Care System.
NCT01792544 is a NA study of Echocardiography that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 1,706 participants, above the 385-participant average among 4 other Echocardiography trials with a reported enrollment target (343% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01792544, a NA study of Echocardiography, has completed, sponsored by VA Palo Alto Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,706 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the impact of adding a statement to the echocardiography report that advises anyone reading the report regarding if and when a follow-up study is recommended.
Primary Outcome
Performance of a follow-up echocardiogram when it was not indicated or not performing for a follow-up echocardiogram when it was indicated.
Conditions Studied
Interventions
- OTHER Statement
- OTHER No Statement
Study Locations (1)
California
- VA Palo Alto HCS - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,706 participants |
| Start Date | 2011-07 |
| Est. Completion | 2015-07 |
| Phase | NA |
What the finished NCT01792544 record still lists
NCT01792544 is an interventional study that assigns participants to a tested intervention. Its 1,706 participants enrollment target places it among the larger protocols in the corpus, above the 385-participant average among 4 other Echocardiography trials with a reported enrollment target (343% higher).
The record links to 1 condition, with Echocardiography appearing as the primary indexed condition, and to 2 interventions - of which Statement is the first listed.
NCT01792544 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01792544 about?
NCT01792544 is a clinical study titled "Clinical Reminders in Test Reports to Improve Guideline Compliance". This study examines the impact of adding a statement to the echocardiography report that advises anyone reading the report regarding if and when a follow-up study is recommended.
What is the current status of trial NCT01792544?
This trial is currently completed. It is a NA study. The enrollment target is 1,706 participants. The study started on 2011-07. Estimated completion is 2015-07.
What conditions does trial NCT01792544 study?
This clinical trial studies the following conditions: Echocardiography.
What interventions are being tested in trial NCT01792544?
The interventions under investigation include: Statement (OTHER), No Statement (OTHER).
Who is sponsoring clinical trial NCT01792544?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01792544 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Echocardiography
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Reminder to Improve Appropriateness of Echocardiography
COMPLETED · NA
-
Assessment of Left Ventricular Filling Pressure by Applying Artificial Intelligence Algorithms to Left Atrial Speckle-tracking Echocardiography
RECRUITING
-
Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement
COMPLETED · Phase 2
-
Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
- NCT05303636 · 1,710 participants · Phase 4
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia